Journal of the Society for Gynecologic Investigation

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/rsci

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Speake, P. F.
Right arrow Articles by D'Souza, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Speake, P. F.
Right arrow Articles by Zipitis, C. S.
Right arrow Articles by Houston, A.
Right arrow Articles by D'Souza, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of the Society for Gynecologic Investigation, Vol. 11, No. 7, 472-477 (2004)
DOI: 10.1016/j.jsgi.2004.05.004

Taurine Transport Into Fetal Cord Blood Cells: Inhibition by Cyclosporine A

Paul F. Speake, PhD

Human Development and Reproductive Health Academic Group, Academic Unit of Child Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom; paul.speake{at}man.ac.uk

Christos S. Zipitis, MB ChB

Angela Houston, MB ChB

Stephen D'Souza, MB ChB, PhD

Human Development and Reproductive Health Academic Group, Academic Unit of Child Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom

Objectives: Pregnant women undergoing long-term organ transplant treatment have an increased incidence of delivering infants with intrauterine growth restriction (IUGR). Cyclosporine A is used as an immunosuppressant in such women and indirect evidence suggests that IUGR might result from an effect of cyclosporine A on amino acid transport by the placenta. In this study we tested the hypothesis that the transport of an essential amino acid, taurine, by fetal tissue other than the placenta is modulated by cyclosporine A.

Methods: Cord blood cells (CBCs) were used to test this hypothesis as an easily obtainable fetal tissue. Transport of taurine into CBCs was measured using standard tracer flux assays.

Results: Uptake of [3H] taurine by CBCs was linear over 15 minutes (76.2 ± 16.6 fmol/106 cells/min, mean ± SEM, n = 6) and inhibitable by 10 mM ß-alanine, a substrate of the system-ß taurine transport protein (6.7 ± 1.0 fmol/106 cells/min, n = 6, P < .05 paired Student t test). Pre-incubation with cyclosporine A (5 µM) inhibited [3H] taurine uptake by 29.3%-5.3% (n = 8, P < .05, paired Student t test).

Conclusions: These data show that amino acid transport via system-ß can be measured in CBCs and may be a useful model for amino acid transport studies in fetal cells. We also show that system-ß was inhibited by the immunosuppressant, cyclosporine A. This suggests that the increased incidence of IUGR reported in mothers treated with cyclosporine A may be due partially to effects on taurine uptake into fetal cells outside the placenta.

Key Words: Fetal • blood cells • amino acid transport • taurine • cyclosporine A


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?